Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Eve Holding, Inc. (EVEX)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
$1.57-6.55%
Close 2026-11-05 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for EVEX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Advance flight test phase of eVTOL aircraft prototype | Eve Holding advances testing of its eVTOL prototype, a key step in product development. | Intact | failure to advance flight test phase or major setbacks in prototype testing during 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is speculative growth, not an established earnings compounder. The thesis is in a watch state, with low evidence confidence, weak recent performance, and volatile management signals.
The evidence gives no direct valuation measure or estimate of what the market expects, so whether EVEX is cheap or expensive versus peers is unclear. The loss-making business and high risk point to a large execution gap, while the recent delisting-rule notice adds uncertainty.
Near term, execution remains uncertain: the flight-test phase, capital and credit management, and efforts to reduce losses and improve cash flow are all priorities to watch. Results have been mixed, with an earnings miss in May and a beat in August, while recent performance remains weak versus its industry group and earnings surprises are trending down.
Over the multi-year view, the key question is whether EVEX advances prototype flight testing while reducing operating losses and improving cash flow. Near-term conditions also matter: stronger guidance from industrial bellwethers could support the sector backdrop, while weaker jobs data or weaker bellweller results could deepen cyclical pressure.
The 1-to-3-year thesis is uncertain and execution-dependent, with persistent losses, high risk, and the delisting-rule notice weighing on the setup. Progress on flight testing and cash flow is central to the case. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 1 supplied quarters. Management reported: “With 73 complete flights thus far, our engineering team validated a total of 170 points of the aircraft – component reliability, aircraft performance, systems and sub-system behavior.” “This is equivalent to 91% of the total check points that had been planned for the entire flight campaign of the prototype.”
Manage capital allocation and credit facilities | The company manages credit facilities to support growth. | Intact | loss of credit facilities or inability to secure financing in 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating losses and improve cash flow | Despite losses, management aims to reduce operating losses from negative $66.3M in 2026-Q1. | Broken | operating losses worsen beyond negative $66.3M or cash burn exceeds negative $68.1M in next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Selling, General & Administrative (SG&A) dropped to $6.0 million in 3Q26 ($7.0 million in 3Q25) – mostly in response to reduced outsourced services and other expenses, despite the c.4% average appreciation of the Brazilian Real versus the US Dollar.” “Eve is already capturing some of the additional cost savings and synergies that had been previously identified with Embraer.” Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.63 → $-0.59 · observed estimates
$0.01B → $0.00B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-07-25 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-07-26 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-07-27 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-07-28 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-07-29 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-07-30 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-07-31 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-08-01 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-08-02 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-08-03 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-08-04 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-08-05 | $-0.63 | $9,604,333 | 4 / 6 |
| 2026-08-06 | $-0.65 | $9,604,330 | 4 / 9 |
| 2026-08-07 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-08 | $-0.55 | $6,337,670 | 5 / 9 |
| 2026-08-09 | $-0.55 | $6,337,670 | 5 / 9 |
| 2026-08-10 | $-0.55 | $6,337,670 | 5 / 9 |
| 2026-08-11 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-12 | $-0.56 | $6,337,670 | 4 / 9 |
| 2026-08-13 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-14 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-15 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-16 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-17 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-18 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-19 | $-0.57 | $4,777,778 | 4 / 6 |
| 2026-08-20 | $-0.55 | $4,777,778 | 5 / 6 |
| 2026-08-21 | $-0.55 | $4,777,778 | 5 / 6 |
| 2026-08-22 | $-0.55 | $4,777,778 | 5 / 6 |
| 2026-08-23 | $-0.59 | $4,777,778 | 5 / 6 |
| 2026-08-24 | $-0.59 | $4,777,778 | 5 / 6 |
| 2026-08-25 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-26 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-27 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-28 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-29 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-30 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-08-31 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-01 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-02 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-03 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-04 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-05 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-06 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-07 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-08 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-09 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-10 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-11 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-12 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-13 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-14 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-15 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-16 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-17 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-18 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-19 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-20 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-21 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-22 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-23 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-24 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-25 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-26 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-27 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-28 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-29 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-09-30 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-01 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-02 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-03 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-04 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-05 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-06 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-07 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-08 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-09 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-10 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-11 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-12 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-13 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-14 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-15 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-16 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-17 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-18 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-19 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-20 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-21 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-22 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-23 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-24 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-25 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-26 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-27 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-28 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-29 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-30 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-10-31 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-11-01 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-11-02 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-11-03 | $-0.59 | $4,777,778 | 5 / 7 |
| 2026-11-04 | $-0.59 | $4,777,778 | 5 / 6 |
| 2026-11-05 | $-0.59 | $4,777,778 | 5 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.